Search

everythinglearnresearchcommunity

for

Search:↓

Certain drugs and supplements may contribute to hair loss in the frontal hairline in older women.

The study suggests hormonal factors may play a role in Frontal Fibrosing Alopecia and that treatments like oral antiandrogens and steroids could be beneficial.

PCOS is a long-term condition that needs more research for better understanding and treatment.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Male faces age with more wrinkles and hair loss, influenced by both body changes and environmental factors.

Frontal fibrosing alopecia often occurs after menopause, with delayed diagnosis and possible links to certain medications and conditions.

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.

Up to 50% of women may experience significant hair loss by age 50, with various causes and treatments available.

Men and women experience skin aging differently due to changes in sex hormone levels with age.

Most women had adequate essential elements except zinc, and lead levels were higher in peri-/post-menopausal women.

Free testosterone is the most common hormone marker in PCOS, and age affects DHEAS levels.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Hormone therapy can improve sexual health and quality of life for women 70 and older.

Low iron levels are not linked to hair loss in women with androgenetic alopecia.

Women over forty can maintain skin and hair health with lifestyle and dietary changes.

Many women in Recife lack understanding of the climacteric period, needing better education and care.

PCOS affects many women, causing hormonal issues and health risks, but can be managed with lifestyle changes and medication.

Diffuse alopecia in women may be related to androgens and iron deficiency, and basic hormone and nutrient screening is useful.

Androgenetic alopecia is not caused by low iron levels.

Aromatase inhibitors cause male pattern hair loss in women.

Hormonal therapies like cyproterone acetate and spironolactone may help some women with hair loss, but finasteride 1mg is not useful, and the effectiveness of other treatments is still unclear.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

Women experience various skin issues at different life stages, requiring careful treatment and awareness.

Treatment strategies for breast cancer affect blood health, causing issues like anemia and require nutritional counseling.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

Ki-67 levels do not predict treatment response in triple-negative breast cancer.

PCOS increases the risk of heart disease and type 2 diabetes in women.

Breast cancer survivors may have a higher risk of falls, tamoxifen could prevent breast cancer and deaths, new guidelines urge caution with prostate cancer therapy, and early balding in men may indicate a higher prostate cancer risk.

Women with PCOS are much more likely to have sleep problems and should be checked for them.